Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Analysts

 

Adam Karlsson and Viktor Sundberg, ABG Sundal Collier

Ulrik Trattner, Carnegie

Niklas Elmhammer, Redeye

Dan Akschuti and Johan Unnérus, Pareto Securities

Joseph Hedden, Rx Securities

 

Calendar and upcoming reports

August 19, 2021
Interim report April-June

September 1-2, 2021
Pareto healthcare conference

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com